Antibody‐mediated rejection (AMR) is highly detrimental to the prolonged survival of
transplanted kidneys. C4d has been regarded as a footprint of AMR tissue damage, and the …

Transplant glomerulopathy (TG) is a major cause of chronic graft dysfunction without
effective therapy. Although the histological definition of TG is well characterized, the …

Antibody-mediated rejection (AMR) is caused by antibodies that recognize donor human
leukocyte antigen (HLA) or other targets. As knowledge of AMR pathophysiology has …

Background Chronic active antibody-mediated rejection (c-aABMR) is an important cause of
allograft failure and graft loss in long-term kidney transplants. Methods To determine the …

We studied 92 patients with transplant glomerulopathy to develop a prognostic index based
on the risk factors for allograft failure within five years of diagnosis (Development cohort) …

Transplant glomerulopathy (TG) is associated with poor long‐term allograft survival and is
often accompanied by microcirculation inflammation. Histopathologic scoring may inform …

Introduction Transplant glomerulopathy (TG) becomes increasingly prevalent in kidney
transplant recipients over time, and it is strongly associated with allograft failure. To date, our …

There have been recent significant advances in short‐term outcomes in renal
transplantation, however, long‐term allograft survival remains a challenge. With reported …

Background Screening for donor-specific anti-HLA antibodies (DSA) using bead-based
multiplex assays to determine transplant suitability is standard practice in many countries …

Transplant glomerulopathy is characterized by a post-transplant morphologic insult. It occurs
as a consequence of chronic, periodic injury of endothelial cells triggered by chronic …